Serum free light chain immunoassays: A guide to antigen excess detection

Clinica Chimica Acta

Volumn 413, Issue 9-10, 2012, Pages 949-

  Jenner, Ellen ^a   Levoguer, Alison ^a   Evans, Josie ^a   Harding, Stephen ^a  

^a Binding Site Group Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOIDOSIS; ANTIGEN DETECTION; HUMAN; IMMUNOASSAY; LETTER; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ELECTROPHORESIS; SERUM FREE LIGHT CHAIN IMMUNOASSAY; TURBIDIMETRY;

BIOLOGICAL MARKERS; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN LIGHT CHAINS; NEPHELOMETRY AND TURBIDIMETRY;

EID: 84858624232     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.01.014     Document Type: Letter

References (8)

1. Vercammen M., Meirlaen P., Broodtaerts L., Broek I.V., Bossuyt X. Effect of sample dilution on serum free light chain concentration by immunonephelometric assay. Clin Chim Acta 2011, 412:1798-1804.
2. Dispenzieri A., Kyle R., Merlini G., et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009, 23:215-224.
3. Katzmann J.A., Kyle R.A., Benson J., et al. Screening panels for detection of monoclonal gammopathies. Clin Chem 2009, 55:1517-1522.
4. Murata K., Clark R.J., Lockington K.S., Tostrud L.J., Greipp P.R., Katzmann J.A. Sharply increased serum free light-chain concentrations after treatment for multiple myeloma. Clin Chem 2010, 56:16-18.
5. Bosmann M., Kossler J., Stolz H., Walter U., Knop S., Steigerwald U. Detection of serum free light chains: the problem with antigen excess. Clin Chem Lab Med 2010, 48:1419-1422.
6. Mollee P., Tate J., Dimeski G., Gill D. Falsely low serum free light chain concentration in patients with monoclonal light chain diseases. Blood 2005, 106:5077a.
7. Bird J.M., Owen R.G., D'sa S., et al. Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol 2011, 154:32-75.
8. Kyle R.A., Durie B.G., Rajkumar S.V., et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 2010, 24:1121-1127.